ZY Therapeutics Overview
- Founded
- 2015
- Status
- Private
- Employees
- 8
- Latest Deal Type
- 2ndary - Private
- Financing Rounds
- 2
ZY Therapeutics General Information
Description
Provider of a drug delivery technology platform intended to improve health and extend lives. The company's technology is an innovative drug delivery system (DDS) for the targeted delivery and controlled release of therapeutic agents, enabling the healthcare industry to reduce side effects due to the drug interacting with healthy tissues, which limited treatments for cancer and infectious diseases.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
- Frontier 400, 400 Park Offices Drive
- Research Triangle Park, Suite 310, 311
- Durham, NC 27709
- United States
ZY Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore ZY Therapeutics‘s full profile, request access.
Request a free trialZY Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of a drug delivery technology platform intended to improve health and extend lives. The company's technology is
Drug Delivery
Durham, NC
8
As of 2020
000
0000-00-00
00000000000
0000000
nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
0000 000000000
Tübingen, Germany
000
As of 0000
00.000
00000000
00.000
00000000
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo con
0000000000000
Kashiwa, Japan
00
As of 0000
000.00
0000
0000-00-00
000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialZY Therapeutics Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CureVac | Formerly VC-backed | Tübingen, Germany | 000 | 00.000 | 00000000 | 00.000 |
| 00000000000 | Corporation | Kashiwa, Japan | 00 | 000.00 | 000000000 | 000.00 |
ZY Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jian Bao Ph.D | Co-Founder, Chief Executive Officer & Board Member | ||
| Jun Li Ph.D | Co-Founder, Chief Scientific Officer & Board Member |
ZY Therapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 000 00.0 | ZY Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| 000 00 00.0 | ZY Therapeutics | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
| 00000000 00000 | ZY Therapeutics | Board Member | 000 0000 |
| 0000 0000 | ZY Therapeutics | Board Member | 000 0000 |
ZY Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialZY Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore ZY Therapeutics‘s full profile, request access.
Request a free trial